|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Georgia Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing GeorgiaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
EndoChoice Inc.
| | | Phone: | (888) 682-3636 | Fax: | (866) 567-8218 | Year Established: | 2008 | Ticker: | BSX | Exchange: | NYSE | Main Contact: | Will Parks, Co-Founder & Senior VP, Business Development | | Other Contacts: | David N. Gill, President & CFO Mark Gilreath, Co-Founder & CEO
| | Company Description | EndoChoice focuses on the manufacturing and commercialization of technologies including endoscopic imaging systems, devices and infection control products, and pathology services for specialists treating a wide range of gastrointestinal conditions, including colon cancer. EndoChoice leverages its direct sales organization to serve more than 2,500 customers in the United States and works with distribution partners in 30 countries.
On Nov. 22, 2016, Boston Scientific and EndoChoice Holdings announced the closing iof their agreement under which Boston Scientific agreed to acquire EndoChoice. The total equity value was $210 million. | |
|
|
|
|
|